Understanding how certain genetic factors influence lung disease severity
lncRNAs, Linking Genetic Susceptibility to Molecular Phenotype in IPF
This study is looking at how certain genetic factors and long non-coding RNAs might affect how severe idiopathic pulmonary fibrosis (IPF) can be for different people, with the hope of finding new ways to understand and treat the disease better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | VA Eastern Colorado Health Care System NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10948907 on NIH RePORTER |
What this research studies
This research investigates the role of long non-protein-coding RNAs (lncRNAs) in how genetic variants affect the severity of idiopathic pulmonary fibrosis (IPF). By analyzing genetic data from thousands of patients, the study aims to uncover the molecular mechanisms that contribute to the variability in disease presentation and progression. The researchers will explore how these lncRNAs interact with known risk factors to influence the clinical outcomes of IPF. This could lead to a better understanding of the disease and potential new therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with idiopathic pulmonary fibrosis, particularly those with known genetic risk factors.
Not a fit: Patients with other forms of lung disease or those without a diagnosis of idiopathic pulmonary fibrosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved personalized treatment strategies for patients with idiopathic pulmonary fibrosis.
How similar studies have performed: Previous research has shown promising results in understanding genetic influences on disease, suggesting that this approach could yield valuable insights.
Where this research is happening
Aurora, UNITED STATES
- VA Eastern Colorado Health Care System — Aurora, United States (Active)
Researchers
- Principal investigator: Schwartz, David Albert — VA Eastern Colorado Health Care System
- Study coordinator: Schwartz, David Albert
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.